Výsledky vyhledávání - "Nikita B. Rukhe"

A Review on HPLC Method Development and Validation for Gliptin Class: New Oral Antidiabetic Agents

Autor: Archana B. Gore, Manojkumar K. Munde, Nikita B. Rukhe, Nilesh S. Kulkarni

Publikováno v: Research Journal of Pharmaceutical Dosage Forms and Technology. :79-86

Gliptin is the class of antidiabetic medicine also called as dipeptidylpeptidase-4. DPP-4 (dipeptidyl peptidase-4) inhibitors (or "gliptins") represent a class of oral anti-hyperglycaemic agents that inhibit the enzyme DPP-4, thus augmenting the biol

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4370442ddd8f40ad67550cbf89498d6d
https://doi.org/10.52711/0975-4377.2022.00013

Zobrazit plný text záznamu

A Comprehensive Review on Analytical Method Development and Validation for SGLT-2 Inhibitors by HPLC in Its API and Dosage Form

Autor: Nikita B. Rukhe, Nilesh S. Kulkarni, Manojkumar K. Munde, Dhanya B. Sen

Publikováno v: Research Journal of Pharmacy and Technology. 13:3472

SGLT-2 is the newly developed class of antidiabetic medicine also called as gliflozins. Empagliflozin, dapagliflozin and canagliflozin are the SGLT-2 class inhibitors for the treatment of type II diabetes mellitus. SGLT-2 inhibitors shows the 82% of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::fd4efaa611d4c11ab3a917463dea0956
https://doi.org/10.5958/0974-360x.2020.00616.2

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání